ADIPOQ rs17300539: What Your Genotype Means
The rs17300539 variant is a single nucleotide polymorphism located in the promoter region of the ADIPOQ gene. It is widely studied for its statistical association with circulating levels of adiponectin, a protein that plays a key role in regulating insulin sensitivity and metabolic health.
What each genotype means
Higher metabolic risk profile
Research indicates that individuals with the GG genotype may have lower circulating adiponectin levels compared to those with the A allele. Studies have associated this genotype with an increased risk of insulin resistance and metabolic syndrome traits, though these risks may be modulated by dietary interventions. Please discuss your metabolic health and dietary strategies with your healthcare provider.
This is the most common genotype globally, carried by the vast majority of individuals across most ancestral populations.
Intermediate metabolic profile
This genotype represents a heterozygous state where one copy of the A allele is present. Research suggests the A allele is associated with enhanced promoter activity of the ADIPOQ gene and potentially higher adiponectin levels compared to the GG genotype. As this is a complex trait influenced by many factors, please consult with your clinician regarding your overall metabolic health.
Carried by approximately 1 in 10 people in many European populations, though it is significantly less common or absent in East Asian populations.
Higher adiponectin potential
Individuals with the AA genotype carry two copies of the A allele, which has been linked in research to higher transcriptional activity of the ADIPOQ gene and increased circulating adiponectin levels. While this is statistically associated with favorable metabolic markers in some studies, it is only one of many factors influencing your health. Please discuss your metabolic profile with your healthcare provider.
This is the least common genotype, occurring in a small percentage of the population in most studied groups.
Understanding the rs17300539 Variant
The rs17300539 variant is a specific change in the DNA sequence located within the ADIPOQ gene, which sits on chromosome 3 at position 3q27.3. In genetics, a single nucleotide polymorphism (SNP) like rs17300539 represents a variation at a single position in the genome where one nucleotide is replaced by another. This particular SNP is found in the promoter region of the gene, which is the area responsible for controlling how much of a protein is produced. Because it is located in a regulatory region, researchers have investigated whether this variation influences the expression levels of the adiponectin protein. Scientific studies have identified this variant as a significant marker in fine-mapping studies of the ADIPOQ locus, often appearing in linkage disequilibrium with other nearby variants, meaning these markers are frequently inherited together as a block.
The Role of the ADIPOQ Gene
The ADIPOQ gene provides instructions for making a protein called adiponectin. This protein is an adipokine, a type of signaling molecule secreted primarily by adipose (fat) tissue into the bloodstream. Adiponectin is well-regarded in metabolic research for its insulin-sensitizing, anti-inflammatory, and anti-atherogenic properties. It helps regulate glucose levels and fatty acid breakdown in the body. Because of these functions, the gene is a primary focus for researchers studying metabolic syndrome, type 2 diabetes, and cardiovascular health. When the ADIPOQ gene functions optimally, it helps maintain metabolic homeostasis. Variations in this gene, such as rs17300539, are studied to understand why individuals may have naturally different baseline levels of circulating adiponectin, which in turn may influence their susceptibility to various metabolic conditions.
Research Associations and Evidence
Research into rs17300539 has consistently shown a strong statistical association with serum adiponectin concentrations. Multiple studies, including Mendelian randomization analyses, have linked the minor A allele of this SNP to higher levels of circulating adiponectin. Because higher adiponectin levels are generally associated with improved insulin sensitivity, this variant is a subject of interest in the study of metabolic health. However, the evidence is nuanced; while the association with adiponectin levels is robust, the direct impact on clinical outcomes like diabetes incidence can be complex and influenced by other factors such as BMI, age, and diet. It is important to note that these findings are based on population-level statistical associations. They do not imply a direct cause-and-effect relationship for any single individual, and the strength of these associations can vary across different ethnic and ancestral backgrounds.
Interpreting Your Genetic Information
If you have access to your genetic data, you may see your genotype for rs17300539 listed as GG, GA, or AA. It is crucial to understand that this information is for educational purposes only and should not be used to diagnose or predict personal health outcomes. Genetic variants are only one piece of a much larger puzzle that includes lifestyle, diet, environment, and other genetic factors. You cannot use this information to make medical decisions or change your health regimen. If you are concerned about your metabolic health, insulin sensitivity, or risk for conditions like type 2 diabetes, the most appropriate step is to consult with a healthcare professional. They can provide personalized guidance based on your clinical history, blood work, and overall health profile, rather than relying on a single genetic marker.
How common is this variant?
The rs17300539 variant is considered a common SNP in human populations, with the minor A allele occurring at a frequency that allows it to be studied across diverse ancestral groups.
Frequently asked questions
What does rs17300539 do to my health?
The rs17300539 variant is associated with differences in the amount of adiponectin protein in your blood. It does not determine your health status, as many other factors like diet and exercise play a much larger role in metabolic health.
Is rs17300539 a diagnostic test for diabetes?
No, this variant is not used for diagnosing diabetes or any other medical condition. Genetic associations are statistical observations in large groups and cannot predict individual health outcomes.
Should I change my diet based on my rs17300539 genotype?
You should not change your diet based on this genetic marker. Always consult with a registered dietitian or your primary care physician before making significant changes to your nutrition or lifestyle.
Where can I find more information about ADIPOQ?
You can find reliable information about the ADIPOQ gene and its functions on resources like MedlinePlus Genetics or the NCBI Gene database. These sites provide comprehensive summaries of gene function and related research.
Sources & further reading
Educational information only, last refreshed 10/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17300539?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ADIPOQ
Promoter variant (-11391G>A) in the ADIPOQ gene associated with circulating adiponectin levels.
Common regulatory polymorphism in the ADIPOQ gene associated with circulating adiponectin levels.
This SNP is associated with circulating adiponectin levels and metabolic syndrome risk.
This SNP in the adiponectin gene is associated with insulin sensitivity and metabolic syndrome risk.
A candidate SNP in the adiponectin gene investigated for its potential association with human longevity and aging phenotypes.
A variant in the ADIPOQ gene linked to inflammatory regulation and insulin sensitivity in the context of dietary intake.